Brief: PYC Therapeutics Forms Ophthalmology-Focused Clinical Advisory Board
17/08/2021 12:11
Aug 17 (Reuters) - PYC Therapeutics Ltd PYC.AX :
* PYC THERAPEUTICS ASSEMBLES OPHTHALMOLOGY-FOCUSED CLINICAL
ADVISORY BOARD
* PYC THERAPEUTICS - CLINICAL ADVISORY BOARD WILL INITIALLY
FOCUS
ON VP-001 FOR TREATMENT OF RETINITIS PIGMENTOSA TYPE 11
* PYC THERAPEUTICS - FOR VP-001, EXPECTS LARGER ANIMAL DATA
READOUTS IN 2H 2021, INVESTIGATIONAL NEW DRUG FILING IN MID-2022
Source text for Eikon: ID:nPnbHfNKya
Further company coverage: PYC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director